Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2019 - 2028

Report Overview

The global chemo graded nitrile powder-free medical examination gloves market size was valued at USD 238.3 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2019 to 2028. Increasing cancer prevalence across the globe is expected to boost the demand for chemotherapy, resulting in driving the market. Due to the COVID-19 pandemic, various governments placed lockdown restrictions, resulting in the inability of the hospitals and health care centers to conduct cancer screenings and treatments. This resulted in hindering the overall examination conducted by the oncologists, thereby reducing the demand for chemo graded nitrile powder-free medical examination gloves during the pandemic.

As COVID-19 cases increased rapidly in the U.S. in 2020, the duties of oncologists were shifted toward taking care of COVID-19 patients. This led to a delay in cancer surgeries, reduction in chemotherapy administrations, and in-person visits for cancer treatment. Doctors were instructed to initiate telehealth visits to protect cancer patients from coronavirus exposure. As a result, the demand for disposable gloves mandated for COVID-19 treatment witnessed growth but the demand for chemo graded nitrile powder-free medical examination gloves decreased in the U.S. The use of cancer wards for the treatment of COVID-19 patients further declined the demand for chemo graded nitrile powder-free medical examination gloves globally.

Various government and private organizations, market-based enterprises, and hospitals are working on innovative programs to create public awareness regarding cancer and the benefits of early detection through screening services. Rising awareness pertaining to various types of cancers and their causes is expected to contribute towards the early detection and diagnosis of disease.  Survival rates of patients through radiotherapy, chemotherapy and targeted drug delivery are rising. According to research carried out by Lancet, a medical journal, the demand for chemotherapy is expected to rise from 9.8 million in 2018 to 15.0 million in 2040. Rising demand for chemotherapy is anticipated to have a positive impact on the growth of the market for chemo graded nitrile powder-free medical examination gloves over the forecast period.

Regional Insights

Asia Pacific led the chemo graded nitrile powder-free medical examination gloves market and accounted for a revenue share of 42.1% in 2020 owing to the expanding healthcare industry coupled with stringent regulations intended for the safety of doctors and hospital employees. The use of chemo graded nitrile gloves is rising as it protects healthcare professionals from the side effects caused by chemotherapy drugs handling.

Indian government initiatives aimed at supporting research, raising awareness pertaining to cancer, increased research funding, and implementation of mass screening programs for cancer are likely to increase the number of hospitals and oncology centers, which is expected to generate demand for chemo graded nitrile powder-free medical examination gloves over the forecast period.

The demand for chemo graded nitrile powder-free medical examination gloves is estimated to witness a CAGR of 7.6% in North America over the forecast period. Increased detection of cancer in the early stages, with interventions such as chemotherapy and radiation therapy, is likely to boost healthcare expenditure, in turn, benefitting the market in North America.

In the U.S., the Centers for Disease Control and Prevention’s (CDC) Cancer Prevention and Control section is working in collaboration with territories, state health agencies, tribal organizations, and other government and non-government organizations to promote, implement, and develop effective cancer control and prevention practices which are anticipated to boost chemo graded gloves demand in the country.

Key Companies & Market Share Insights

The manufacturers of chemo graded nitrile powder-free medical examination gloves are focusing on constructing new manufacturing facilities in various counties and expanding their existing facilities to increase the production capacity of gloves. For instance, in April 2019, Top Glove Corporation Bhd started the construction of several new factories, including 3 in Malaysia and 1 each in Thailand and Vietnam, which were completed by December 2020.

The key players are focused on research and development activities to develop improved technologies for the manufacturing of chemo graded nitrile powder-free medical examination gloves and integration across various stages of the value chain to gain a competitive edge in the market. Some of the prominent players in the global chemo graded nitrile powder-free medical examination gloves market include:

• Cardinal Health

• Top Glove Corporation Bhd

• Ansell Ltd.

• Kimberly-Clark Corporation

• Sempermed USA, Inc.

• Halyard Health, Inc.

• Tronex International, Inc.

• McKesson Medical-Surgical Inc.

• Hartalega Holdings Berhad

• Safeko

Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global chemo graded nitrile powder-free medical examination gloves market report on the basis of region:

• Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Russia

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

    • Indonesia

  • Latin America

    • Brazil

    • Argentina

    • Mexico

  • Middle East & Africa

    • Saudi Arabia

    • UAE

    • South Africa